HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

6- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- one

structure in first source
Also Known As:
PF 228; PF 573,228; PF 573228; PF-228; PF-573,228; PF-573228; PF228 cpd; PF573,228; PF573228
Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Haromy, Alois: 1 article (02/2014)
2. Paulin, Roxane: 1 article (02/2014)
3. Bonnet, Sébastien: 1 article (02/2014)
4. Bonnet, Pierre: 1 article (02/2014)
5. Courchesne, Antony: 1 article (02/2014)
6. Michelakis, Evangelos D: 1 article (02/2014)
7. Provencher, Steeve: 1 article (02/2014)
8. Meloche, Jolyane: 1 article (02/2014)
9. Courboulin, Audrey: 1 article (02/2014)
10. Lambert, Caroline: 1 article (02/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Pituitary Neoplasms (Pituitary Adenoma)
3. Right Ventricular Hypertrophy
4. Ovarian Neoplasms (Ovarian Cancer)
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Focal Adhesion Protein-Tyrosine Kinases
2. Small Interfering RNA (siRNA)
3. Monocrotaline
4. Drug Combinations
5. N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamide
6. gefitinib (Iressa)
7. temozolomide (Temodar)
8. tranilast (N 5')